[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100563194":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":31,"centralContacts":39,"locations":31,"responsibleParty":45,"collaborators":31,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":31,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":31,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":70,"overallStatus":73,"whyStopped":31,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":31},{"fullName":5,"class":6},"Al-Azhar University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Tramadol group","EXPERIMENTAL","Intravenous Tramadol",[13],"Drug: Tramadol",{"label":15,"type":10,"description":16,"interventionNames":17},"Magnesium sulphate group","Intravenous Magnesium Sulphate",[18],"Drug: Magnesium sulphate",{"label":20,"type":21,"description":22,"interventionNames":23},"Control group","PLACEBO_COMPARATOR","Saline",[24],"Other: Saline",[26,32,36],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"DRUG","Tramadol","Intravenous tramadol",[9],null,{"type":27,"name":33,"description":34,"armGroupLabels":35,"otherNames":31},"Magnesium sulphate","Intravenous magnesium sulphate",[15],{"type":6,"name":22,"description":37,"armGroupLabels":38,"otherNames":31},"Normal saline",[20],[40],{"name":41,"role":42,"phone":43,"phoneExt":31,"email":44},"Warda Demerdash Ali, PhD","CONTACT","088 2148087","warda2001@hotmail.com",{"type":46,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"PRINCIPAL_INVESTIGATOR","Warda Demerdash Khalifa Ali","Dr","100563194","phase-4-intravenous-tramadol-and-magnesium-sulphate-for-prevention-of-shivering-100563194",false,"NCT06612996","Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering","Comparative Study Between Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering Post Intrathecal Anesthesia a Randomized Clinical Study","Inclusion Criteria:\n\n\\- American Society of Anesthesiologists (ASA) I and II physical status undergoing an elective surgery under spinal anesthesia.\n\nExclusion Criteria:\n\n* history of uncontrolled comorbidities, cardiac, respiratory, renal or hepatic disease, patients who had allergy to any medication in the study, contraindications to spinal anesthesia (coagulation disorder, infection at site of puncture, raised intracranial tension or any spine deformity), fever \\>38 Celsius or less than 36 Celsius, body mass index more than 35 and who has history of alcohol intake","ALL","21 Years","60 Years",{"count":60,"type":61},180,"ESTIMATED","INTERVENTIONAL",[64],"PHASE4","The aim of this work was to compare the efficacy of intravenous (IV) tramadol versus magnesium sulphate added to 100 ml saline for prevention of shivering associated with spinal anesthesia.",[67,68,69],"Lower Extremity Chronic Venous Ulcers","Varicose Veins Leg","Hernia",[28,71,72],"Magnesium Sulphate","Shivering","NOT_YET_RECRUITING","2024-09-23",{"date":76,"type":77},"2024-09-25","ACTUAL",{"date":79,"type":61},"2024-10-10",{"date":81,"type":61},"2025-01-10",{"name":5,"class":6}]